In a discussion with The Regulatory Review, I. Glenn Cohen offers his thoughts on the regulatory landscape of medical ...

Just because pulsed field ablation therapy has yet to make its mark in the U.S. by clearing the FDA, that doesn’t mean there’s any reason to wait on developing version 2.0. Field Medical is already ...